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One of the vital functions of the nervous system is to provide
information about the occurrence of injury or dysregulation likely
to threaten the integrity of the organism. By its inherent aversive
nature, the sensation of pain contributes normally to this function
(Meyer et al, 1994). In the cancer patient, however, it is common
to diagnose the presence of a tumoural process several months or
years after onset and often after metastatic dissemination. The
absence of discernible abnormal symptoms such as painful sensa-
tions is often the origin of such delayed diagnosis (Krakowski
et al, 1996). Since cancer can be viewed as a breakdown in cellular
communication processes (Morgan and Curran, 1991), the absence
of such signs may be indicative of a dysregulation in the sensory
transmission between the tumour and/or its environment and the
central nervous system so that no signal would be provided to
inform the organism about the existence of potential injury. Either
the presence of a tumoural process does not provoke functional
alterations in the nervous system activity, or the nervous system
fails to respond appropriately to signals from the tumour, these
failures resulting, at least during the first steps of development, in
an insidious tumoural proliferation.
Owing to the total lack of experimental studies focusing on this
topic, the main goal of the present study was to find out whether a
tumour, the MAT-LyLu prostatic adenocarcinoma (Isaacs et al,
1981) grafted in the hind limb of rats, could be the origin of partic-
ular sensory information to the spinal cord, the first synaptic struc-
ture crossed by peripheral afferent inputs, using the expression of
the c-fos gene as a marker of neuronal activity (Hunt et al, 1987;
Morgan et al, 1987). The c-fos proto-oncogene, which becomes
rapidly and transiently expressed following calcium influx through
voltage-gated channels (Morgan and Curran, 1986), is closely
linked to a messenger cascade coupling cell stimulation to gene
expression (Morgan and Curran, 1991). Since numerous studies
have emphasized the utility of monitoring Fos protein expression
in spinal post-synaptic neurons to map the pattern of neuronal
input to spinal sites (Hugues and Dragunow, 1995; Munglani and
Hunt, 1995) Fos-like immunoreactivity (FLI) was evaluated in
spinal cord neurons of tumour-bearing rats at various times of
tumour development. Histological analyses were conducted in
parallel to determine changes occurring during the tumour growth
in the grafted hind limbs.
MATERIALS AND METHODS
Chemicals
Standard rodent chow was obtained from Pietrement (Provins,
France), rabbit anti-Fos polyclonal IgG from Santa Cruz Biotech.
(sc-52; Santa Cruz, CA, USA), avidin–biotin–peroxidase complex
anti-rabbit IgG from Vector Laboratories (Burlingame, CA, USA).
Other usual laboratory chemicals and reagents were from Sigma
Chemical Co. (St Louis, MO, USA).
Rats and tumour cells
All animal procedures were performed in compliance with strict
institutional guidelines. Experiments were performed on 3-month-
old male Copenhagen rats (200–250 g), housed at standardized
conditions (20°C; alternating 12 h light–dark cycle) with chow
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and fluid given ad libitum. MAT-LyLu prostatic adenocarcinoma
cells were routinely maintained in culture at 37°C under 5%
carbon dioxide atmosphere, in RPMI-1640 medium (Eurobio, Les-
Ullis, France) supplemented with L-glutamine (2 mM), penicillin
(100 U ml–1), streptomycin (50 mg ml–1) (Biomérieux, Marcy-
l’étoile, France) and 10% heat-inactivated fetal calf serum. A
tumoural process was induced by intramuscular inoculation of
2.106 viable carcinoma cells in the right hind limb of the rat.
Healthy control rats received an equal volume of saline vehicle.
Tumour volume was determined with callipers as previously
reported (Moulinoux et al, 1984). Rats were killed at various post-
inoculation periods: 5, 10, 15 and 20 days after tumour graft.
Histology
Tumours were systematically removed, immediately fixed in 10%
formaldehyde and then embedded in paraffin. Four-micrometer
sections obtained with a microtome were spread on glass slides and
dried at 37°C during 48 h. Dewaxing was performed by immersion
in toluene. After progressive rehydration (immersion in ethanol,
then in phosphate-buffered saline (PBS)), slides were stained with
haematoxylin-eosin and saffron, and then examined.
Immunohistochemistry
Animals were deeply anaesthetized and perfused intracardially
with 50 ml 0.1M PBS followed by 500 ml of 4% paraformaldehyde
in 0.1 M phosphate buffer (PB) pH 7.4. The spinal cord was
removed, post-fixed for 2 h in the same fixative, cryoprotected
overnight in 30% sucrose in PB at 4°C, frozen in isopentane
cooled down to –70°C with liquid nitrogen and kept at –80°C.
Frozen 40-mm frontal sections were cut and collected in PB. The
serial sections were immunostained for Fos-like protein using the
avidin–biotin–peroxidase method (Hsu et al, 1981). The tissue
sections were incubated for 30 min at room temperature in a
blocking solution of 10% normal goat (NG) serum in PBS with
0.3% Triton-X (10% NGST); the sections were then incubated for
48 h at room temperature in the anti-Fos IgG diluted at 1:2000
in 1% NGST. After three washes in 1% NGST, sections were
incubated overnight at 4°C with biotinylated goat anti-rabbit IgG
diluted at 1:200 in 1% NGST, then washed twice in 1% NGST and
incubated for 1 h with avidin–biotin–peroxidase complex. Finally,
the sections were washed three times in PB, developed for 2 min
in a solution of PBS containing 0.2 mg ml–1 diaminobenzidine and
14 ml ml–1 hydrogen peroxide, and washed three times in cold PB
to stop the reaction. Sections were mounted on gelatine-subbed
slides, dried at room temperature before being transferred in
alcohol, then in xylene and finally coverslipped.
Fos-labelled cell counts
Tissue sections were first examined using dark-field microscopy to
determine the segmental level as previously described (Molander
et al, 1984), and the grey matter landmarks. The sections were then
examined under light-field microscopy to localize Fos-positive
cells. Labelled nuclei were counted using a camera lucida attach-
ment. The Fos-like immunoreactive neurons were observed from
the lower thoracic to the upper sacral segments and studied more
particularly through the L2–L5 lumbar spinal segments where
most Fos-positive neurons were localized. For each rat, three
sections per segment were examined. Referring to Presley et al
(1990) the number of Fos immunoreactive neurons in the spinal
grey matter was determined in the four regions defined: superficial
dorsal horn (Laminae I and II), nucleus proprius (Laminae III and
IV), neck of the dorsal horn (Laminae V and VI) and the ventral
grey matter (Laminae VII, VIII, IX and X). Throughout the data
collection phase, the investigator was blind to time of graft.
Statistical analysis was made, using the non-parametric
Mann–Whitney ranking test.
RESULTS
Growth rate of the tumour
Tumoural growth is reported in Table 1. The MAT-LyLu prostatic
adenocarcinoma became palpable within 5 days and continued to
grow rapidly until 15 days post-injection. The growth rate slowed
down during the last survival 5 days.
Histological observations
Histological data of grafted limbs at various time after tumour
graft are reported in Table 2. Stained sections showed that all
constitutive components of the limb were progressively infiltrated
by tumour cells until their total destruction after 20 days of
growth. The period ranging from 5 to 10 days post-inoculation,
when tumour growth was exponential, was characterized by a
centrifuge proliferation of tumour cells, with no or very moderate
necrosis and bleeding. Important intra-tumoural haemorrhages and
wide necrotic fields were observed at day 20. The intramuscular
innervation remained unaffected until day 10. Twenty days after
the graft, no nerves could be observed inside the tumoural tissues
and nerves observed at the periphery were squashed. No major
inflammatory reaction accompanied the tumour development.
Little oedema (score 1 on a scale of 0–4) was observed at the
periphery of the tumour till day 10 and was absent (score 0)
thereafter. At every stage of the tumour growth, the density of
inflammatory cells was very low inside the tumour except in
necrotic areas where numerous polynuclear leucocytes were
found.
General behavioural observations
With the exception of cachexy which appeared after 2 weeks of
tumour growth, rats did not manifest abnormal spontaneous
behaviour. No vocalization and/or aggressiveness was spon-
taneously observed either during walking or when the tumour
volume was measured with callipers, an experimental situation
which needs a weak mechanical pressure over the grafted limb.
No particular biting or licking of the grafted limb were observed
even when the tumour volume has largely expanded. During
Table 1 Growth of the MAT-LyLu adenocarcinoma grafted in rats
(mean ± s.e.m.)
Days after graft Tumour size
(cm3)
5 1.4 ± 0.3
10 3.4 ± 0.5
15 10.9 ± 2.3
20 18.0 ± 3.3locomotion both hind paws were on the floor, at least until the
third week when the size of the tumour became an indrance for a
normal use of the limb.
Fos expression in tumour-bearing rats
Growth of the MAT-LyLu carcinoma in the hind limb induced the
expression of the Fos protein in spinal grey matter. Whereas in
healthy rats the few labelled neurons detected were sparsely and
bilaterally distributed throughout the entire grey matter, in tumour-
bearing rats Fos-immunoreactive neurons were mainly confined to
the side of the spinal cord ipsilateral to the grafted hind limb and
more particularly in the lumbar segments (Figures 1 and 2).
Rostral and caudal to the lumbar enlargements the number of
positive cells rapidly diminished and no difference in the Fos-like
immunoreactivity was detected between healthy and tumour-
bearing rats at these levels (data not shown). Fos-like immuno-
reactivity (FLI) evoked by tumour graft was time dependent
(Figure 2). By 5 days after graft, while tumours were still scarcely
palpable (Table 1), the number of Fos-immunoreactive neurons
increased twofold in the ipsilateral side as compared with healthy
rats. Maximum Fos-like immunoreactivity was observed 10 days
after tumour cell inoculation, both in terms of numbers of positive
neurons (threefold increase), and in labelling intensity. Thereafter
FLI dropped although the tumour was still expanding. The
decrease observed 15 days after tumour graft was more marked
5 days later: after 20 days of tumour growth, Fos labelling dropped
by 50% and tended to control values (Figure 2).
Analysis of the rostrocaudal distribution of FLI showed that
from 5 to 15 days of tumour growth, most labelled neurons were
located between the L3 and the L5 spinal segment levels with a
maximum in the L4 segment (Figure 3). Twenty days after tumour
graft, a similar number of Fos-immunoreactive neurons were
observed in the four lumbar segments.
Laminar distribution of Fos labelling in segment L4, showed
major differences depending on the time course of tumour
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Table 2 Histological modifications occurring in grafted limbs during the time course of MAT-LyLu growth
Time after graft
5 days 10 days 20 days
Tumoural tissue Small well-individualized Well-formed tumours Major proliferation
foci of proliferating cells;
Centrifuge growth Centrifuge growth
Intra-tumoural necrosis + + ++++
Intra-tumoural bleeding 0 0 ++++
Angiogenesis ++ ++ ++++
(tumoural, peripheral) (intra-tumoural) (intra-tumoural)
Peripheral tissue Invasion by tumour cells Considerable Complete destruction
(muscle) with little muscle centrifuge muscle of muscle tissue
destruction destruction
Innervation (muscle) Normal Normal Total destruction inside
the tumour; peripheral
nerves compressed
CONTRA
DC
DLF
250mm
IX
CC
IPSI
Figure 1 Photomicrograph illustrating the location of Fos-like
immunoreactive neurons, in a 40 mm section of L4 segment, in tumour-
bearing rat 10 days after graft. Note that the densest labelling is present on
the side of the spinal cord ipsilateral to the grafted hindlimb. Black arrow
points to labelled cells in the superficial dorsal horn; white arrow points to
labelled cells in the ventral horn. CC, central canal; DC, Dorsal columns;
DLF, Dorsolateral funiculus
Figure 2 Histogram presenting the total number of Fos immunoreactive
neurons in the lumbar spinal enlargement, from L2 to L5 in the two sides of
the spinal cord, at different stages of the tumour growth. Five groups of rats
are considered: control rats (n = 4) and tumour-bearing rats, 5 days (n = 4),
10 days (n = 4), 15 days (n = 4) and 20 days (n = 4) after graft. Results are
expressed as mean (± s.e.m.) number of Fos immunoreactive neurons for
four lumbar segments per 3 ´ 40-mm sections. Significance is expressed
taking as reference the control group (*P < 0.05) or the respective
contralateral side (#P < 0.05)
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development (Figure 4). By 10 days of tumour growth, a threefold
increase in the number of Fos-immunoreactive neurons was
observed in the superficial dorsal horn (laminae I and II). Labelled
neurons were sparsely distributed into these laminae and were not
concentrated in any particular area. A high density of labelled
neurons was also found in the neck of the dorsal horn (laminae V
and VI) where their number was enhanced fourfold. The most
extensive Fos labelling was nevertheless observed in the ventral
grey matter (sixfold increase) and more particularly in laminae
VII, VIII and around the central canal (X). Lamina IX was devoid
of labelling. In the nucleus proprius (laminae III and IV), no
significant changes were found between healthy and tumour-
bearing rats. After 20 days of graft, the Fos-like immunoreactivity
dropped significantly in deep laminae, i.e. in the neck of the dorsal
horn and in ventral regions of the spinal cord. In contrast, no
significant drop of FLI was observed between 10 and 20 days of
graft in the superficial dorsal horn.
DISCUSSION
Our present results demonstrate that a tumour growing in the hind
limb of rat triggers spontaneously, that is in absence of any
deliberate additional stimulation, the expression of the Fos protein
in specific regions of the spinal cord. Most labelled neurons
evoked by the tumour graft were detected ipsilaterally at the
L3–L5 levels, consistent with the somatotopic organization of the
primary afferent fibres that innervate the grafted hind limb
(Molander et al, 1984; Swett and Woolf, 1985). Because spinal
Fos expression reflects neuronal activity (Hunt et al, 1987;
Morgan et al, 1987), the present observations demonstrate the
existence of a primary afferent transmission from the peripheral
tumour and/or the adjacent tissues to the spinal cord. The persis-
tence of Fos expression for at least 2 weeks after tumour graft, that
is well beyond the half-life of the Fos protein (Müller et al, 1984)
is indicative of continuous afferent drive and/or of the develop-
ment of spontaneous/central activity of neurons in the spinal cord.
Fos-like immunoreactivity evoked by the tumour graft was time-
dependent. As soon as 5 days after graft, when tumours were still
scarcely palpable, a significant number of labelled neurons were
detected, demonstrating that sensory information is transmitted at
an early stage of tumour growth. Maximum Fos labelling was
observed 10 days after graft when the tumour had the highest rate
of growth. Thereafter, the tumour was still expanding, though
more slowly, and the Fos labelling dropped. This bell-shaped time-
course of Fos expression may be indicative of modifications in
signal transmission and/or in central activity. The nature of these
signals sent by the tumour and which provoked functional alter-
ations in the spinal cord activity remains then to be determined.
Since the first report by Hunt et al (1987), spinal Fos expression
has been largely used as a neuronal marker of pain (Harris, 1998).
However, non-noxious stimulation also triggers spinal Fos-like
immunoreactivity (Jasmin et al, 1994). Fos expression should be
considered as a general marker of neuronal activity rather than a
specific marker of pain. Regarding the general behaviour, the
tumour-bearing rats did not manifest any discernible signs of pain
either spontaneously or during manipulation whatever the stage of
tumour growth. Thus, rats did not manifest particular behaviour
compared to control when the tumour size was evaluated.
Consistent with these observations, our histological studies of the
grafted limbs revealed that no inflammatory reaction accompanied
the tumour growth. From the foregoing observations it seems then
unlikely that spinal Fos expression observed in tumour-bearing
rats is related to pain. Besides, the general pattern of Fos
immunoreactivity in the spinal grey matter of grafted rats differed
in several aspects from those observed after chronic injury-
induced pain. After 5–10 days of graft, when the tumour rapidly
expanded, Fos labelling was detected in the superficial laminae, in
the neck of the dorsal horn, but the maximum immunoreactivity
was located in deeper laminae (VII, VIII) and around the central
canal (X). These findings contrast with neuropathic models of pain
where Fos expression predominates in the nucleus proprius
(laminae III and IV) (Molander et al, 1992; Chi et al, 1993).
Conversely, in models of chronic inflammatory pain, such as
polyarthritis, labelled neurons are mainly located in the neck of the
dorsal horn (Abbadie and Besson, 1992). The observed localiza-
tion of Fos-like immunoreactive neurons in tumour-bearing rats
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Figure 3 Histogram presenting the rostrocaudal distribution in the lumbar
enlargement (from L2 to L5) of the number of Fos immunoreactive neurons
at different times after tumour graft. Results are expressed as mean
(± s.e.m.) number of Fos immunoreactive neurons for four lumbar segments
per 3 ´ 40-mm sections. Significance is expressed taking as reference the
control group (*P < 0.05)
Figure 4 Effects of the tumour graft on the laminar distribution of the Fos
immunoreactive neurons in the ipsilateral L4 segment. Comparison between
control (n = 6) and tumour-bearing rats, 10 days (n = 6) and 20 days (n = 7)
after graft. Results are expressed as mean (± s.e.m.) percentages of control
values of Fos immunoreactive neurons. Significance is expressed taking as
reference the control group (*P < 0.05; **P < 0.01) or tumour-bearing rats
after 10 days of graft (# P < 0.01)
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would best fit the pattern observed in monoarthritic rats (Lanteri-
Minet et al, 1993) even if the time-courses differ. In tumour-
bearing rats, the detection of Fos labelling in nociceptive
responding areas (Besson and Chaouch, 1987) is not in conflict
with our previous suggestions since these areas are not specific for
pain (Bennet et al, 1980; Menetrey, 1987). Thus, the presence of a
tumoural process provokes functional alterations in spinal cord
activity, demonstrating that a tumour actively proliferating in the
limb sends afferent signals to the central nervous system, signals
which are probably unrelated to pain.
The tumour context is a quite complex situation with multiple
components which may have an impact on central nervous system
activity. Mechanical compression of the neighbouring muscles
and nerves as well as overstretching of the surrounding skin
may constitute important stimuli. Nevertheless, spinal Fos was
intensely expressed at an early stage of tumour growth, when these
mechanical factors are minimal. Pharmacologically active
compounds synthesized and released by the tumour cells are prob-
ably involved in this neuronal activity. In particular, polyamines,
biogenic amines with important regulatory functions in the pro-
liferation of malignant cells (Jänne et al, 1978; Marton and Pegg,
1995), are also known to play physiological roles in intracellular
signal processing and neurotransmission. Among the polyamines,
spermine and to a lesser extent spermidine affect neuronal
excitability by interacting with ion channels and/or receptors
coupled to these channels, including some glutamate receptors
(NMDA, AMPA/Kainate) that drive neurons (reviewed in
Williams, 1997). Recent reports have evidenced the presence of
these receptors on peripheral sensory afferents (Carlton et al, 1995;
Zhou et al, 1996). E-type prostaglandins have also been detected in
tumour effusion of the MAT-LyLu adenocarcinoma (Clayton et al,
1985; Shaw et al, 1985). These compounds interact on several
types of ion channels to sensitize sensory neurons (Martin et al,
1987). Despite the release of these well-known inflammatory
compounds, the growth of the MAT-LyLu adenocarcinoma is not
accompanied by an inflammatory reaction. Because spermine has
recently been shown to protect mice against the development of
carrageenan-induced inflammation (Zhang et al, 1997), it is
tempting to speculate that the facilitatory effect of E-type
prostaglandins may be counterregulated by polyamines present in
great amount in the tumour. Taken together, these observations
may suggest that peripheral afferent fibres would be less sensitive
to modifications of their environment or would convey altered
peripheral information. Spinal neuronal activity in these condi-
tions would reflect these modified afferent inputs. Such a hypo-
thesis could explain the similar topology of spinal activity
observed in tumour-bearing and monoarthritic rats. The tumour
development would also drive the polymodal c-fibres. And never-
theless, the information did not seem to be perceived as such since
tumour-bearing rat did not exhibit any characteristics associated
with inflammation.
In conclusion, these results demonstrate that signals are sent to
the central nervous system by the peripheral MAT-LyLu tumour.
But, considering both the behavioural and histological observa-
tions, it is unlikely that spinal activity reflects a painful state.
Actually we cannot rule out the possibility of a central effect.
However, it is tempting to speculate that peripheral tumours may
send altered signals to the central nervous system, masking in
some way the existence of tumour-induced injuries. The nature of
these signals, inefficient to trigger the appropriate reaction of the
organism against the tumour, remain to be determined with regard
to the pharmacologically active compounds synthesized and
released by the tumour cells.
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